Jennifer Lachey is CSO at Keros Therapeutics, Inc. (KROS). They have made 17 open-market trades across 1 company since 2021, most recently 2022-07-15.
CIK 0001808322
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KROS | 141,134 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2022-07-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KROS | SELL | 2022-07-15 | 2022-07-19 | $30.00 | $1.4M | +11.3% | +31.4% | +60.5% |
| KROS | SELL | 2022-07-13 | 2022-07-15 | $30.00 | $57K | +9.6% | +30.0% | +48.6% |
| KROS | SELL | 2022-05-11 | 2022-05-13 | $41.65 | $362K | -22.0% | -36.6% | -13.3% |
| KROS | SELL | 2022-04-11 | 2022-04-13 | $62.70 | $630K | -19.3% | -33.1% | -56.0% |
| KROS | SELL | 2022-04-04 | 2022-04-06 | $60.00 | $477K | -5.5% | -29.0% | -56.9% |
| KROS | SELL | 2022-03-11 | 2022-03-15 | $53.11 | $197K | -1.2% | +24.9% | -46.7% |
| KROS | SELL | 2022-02-11 | 2022-02-15 | $52.02 | $265K | -1.5% | -0.3% | -19.2% |
| KROS | SELL | 2022-01-11 | 2022-01-13 | $53.87 | $268K | -5.5% | +5.9% | +33.8% |
| KROS | SELL | 2022-01-05 | 2022-01-07 | $60.00 | $159K | -9.4% | -1.5% | +28.6% |
| KROS | SELL | 2021-12-13 | 2021-12-15 | $50.29 | $210K | +7.6% | -1.7% | -3.5% |
| KROS | SELL | 2021-11-10 | 2021-11-12 | $59.89 | $1.5M | -5.5% | -20.9% | -15.2% |
| KROS | SELL | 2021-11-04 | 2021-11-05 | $50.00 | $530K | +9.8% | -1.7% | -21.3% |
| KROS | SELL | 2021-06-11 | 2021-06-15 | $50.75 | $212K | -13.3% | -23.6% | -40.3% |
| KROS | SELL | 2021-05-11 | 2021-05-13 | $50.00 | $133K | +9.4% | +14.4% | -25.0% |
| KROS | SELL | 2021-04-12 | 2021-04-14 | $59.91 | $585K | +3.7% | -20.6% | -35.4% |
| KROS | SELL | 2021-03-11 | 2021-03-15 | $64.48 | $683K | -7.4% | -3.8% | -17.3% |
| KROS | SELL | 2021-02-11 | 2021-02-16 | $64.94 | $641K | +9.2% | -8.3% | -15.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.